Browsing Tag
Myriad Genetics Inc.
2 posts
Myriad Genetics stock surges as Labcorp buys prenatal testing business for $210m
Myriad Genetics is selling its prenatal testing business to Labcorp for $210 million. See why $MYGN surged and what the deal means for both companies.
FDA approval positions MyChoice CDx as key HRD test for ovarian cancer therapy selection
Myriad Genetics secures FDA approval for MyChoice CDx with Zejula. Discover how this reshapes oncology diagnostics and precision medicine markets.